New shot for high blood pressure passes first safety check in healthy volunteers
NCT ID NCT07529600
First seen May 06, 2026 · Last updated May 24, 2026 · Updated 6 times
Summary
This early-stage study tested a single shot of ART101 in 40 healthy adults to see if it is safe and how the body processes it. The goal is to gather information for future research on controlling high blood pressure. Participants received one injection and were monitored for side effects and drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION (HTN) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Friendship Hospital, Capital Medical University
Beijing, China
-
Suzhou Arnatar Therapeutics Co., Ltd
Suzhou, Jiangsu, China
Conditions
Explore the condition pages connected to this study.